Isser, Ariel
Silver, Aliyah B.
Pruitt, Hawley C. http://orcid.org/0000-0002-8189-5031
Mass, Michal
Elias, Emma H.
Aihara, Gohta http://orcid.org/0000-0002-2492-9610
Kang, Si-Sim http://orcid.org/0000-0001-9448-447X
Bachmann, Niklas http://orcid.org/0000-0001-8169-1592
Chen, Ying-Yu
Leonard, Elissa K.
Bieler, Joan G.
Chaisawangwong, Worarat
Choy, Joseph http://orcid.org/0000-0001-6282-9437
Shannon, Sydney R.
Gerecht, Sharon
Weber, Jeffrey S.
Spangler, Jamie B. http://orcid.org/0000-0001-8187-3732
Schneck, Jonathan P. http://orcid.org/0000-0001-5346-2776
Article History
Received: 20 April 2022
Accepted: 23 September 2022
First Online: 14 October 2022
Competing interests
: J.P.S. is entitled to shares of royalty under a licensing agreement between NexImmune and Johns Hopkins University. J.P.S. and J.S.W. own NexImmune stock, which is subject to certain restrictions under University policy, and both are members of the company’s Scientific Advisory Board. The terms of these arrangements are being managed by Johns Hopkins University and New York University, respectively, in accordance with their conflict-of-interest policies. The remaining authors declare no competing interests.